E-LIB Suche - Ergebnisse für: Perera, Yasser

1

Gene expression profiling unveils the temporal dynamics of ..:

Vázquez-Blomquist, Dania ; Ramón, Ailyn C ; Rosales, Mauro...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318747/. , 2023

Link: http://www.ncbi.nlm.nih...

2

CIGB-300-Regulated Proteome Reveals Common and Tailored Res..:

Rosales, Mauro ; Rodríguez-Ulloa, Arielis ; Pérez, George V...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962202/. , 2022

Link: http://www.ncbi.nlm.nih...

3

Clinical-grade peptide-based inhibition of CK2 blocks viabi..:

Perera, Yasser ; Melão, Alice ; Ramón, Ailyn C...
info:eu-repo/grantAgreement/EC/H2020/648455/EU. , 2022

Link: http://hdl.handle.net/10..

4

Positive effects of Phycocyanobilin on gene expression in g..:

Gardón, Daniel Palenzuela ; Cervantes-Llanos, Majel ; Matamoros, Beatriz Piniella...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253351/. , 2022

Link: http://www.ncbi.nlm.nih...

5

Phosphoproteomic Landscape of AML Cells Treated with the AT..:

Rosales, Mauro ; Rodríguez-Ulloa, Arielis ; Besada, Vladimir...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915770/. , 2021

Link: http://www.ncbi.nlm.nih...

6

Clinical-Grade Peptide-Based Inhibition of CK2 Blocks Viabi..:

Perera, Yasser ; Melão, Alice ; Ramón, Ailyn C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352628/. , 2020

Link: http://www.ncbi.nlm.nih...

7

Preclinical efficacy of CIGB-300, an anti-CK2 peptide, on b..:

Gottardo, Maria F ; Capobianco, Carla S ; Sidabra, Johanna E...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477577/. , 2020

Link: http://www.ncbi.nlm.nih...

8

Synergistic interactions of the anti-casein kinase 2 CIGB-3..:

PERERA, YASSER ; TORO, NEYLEN DEL ; GOROVAYA, LARISA...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2014

Link: http://www.ncbi.nlm.nih...

9

CIGB-300, a proapoptotic peptide, inhibits angiogenesis in ..:

Farina, Hernán Gabriel ; Benavent Acero, Fernando Rodrigo ; Perera, Yasser...
info:eu-repo/semantics/altIdentifier/url/https://linkinghub.elsevier.com/retrieve/pii/S0014482711001467. ,

Link: http://hdl.handle.net/11..

10

Preclinical efficacy of CIGB-300, an anti-CK2 peptide, on b..:

Gottardo, María Florencia ; Capobianco, Carla Sabrina ; Sidabra, Johanna Elena...
info:eu-repo/semantics/altIdentifier/url/http://www.nature.com/articles/s41598-020-71854-6. ,

Link: http://hdl.handle.net/11..

11

CIGB-300, an anti-CK2 peptide, inhibits angiogenesis, tumor..:

Benavent Acero, Fernando Rodrigo ; Capobianco, Carla Sabrina ; Garona, Juan...
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S016950021630352X. ,

Link: http://hdl.handle.net/11..

12

CIGB-300, a proapoptotic peptide, inhibits angiogenesis in ..:

Farina, Hernán Gabriel ; Benavent Acero, Fernando Rodrigo ; Perera, Yasser...
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/abs/pii/S0014482711001467. ,

Link: http://hdl.handle.net/11..

13

CIGB-300, a synthetic peptide-based drug that targets the C..:

Perea, Silvio E ; Baladron, Idania ; Garcia, Yanelda...
info:eu-repo/semantics/altIdentifier/url/https://link.springer.com/article/10.1007/s11010-011-0950-y. ,

Link: http://hdl.handle.net/11..

14

Pharmacologic inhibition of the CK2-mediated phosphorylatio..:

Perera, Yasser ; Pedroso, Seidy ; Borras-Hidalgo, Orlando...
info:eu-repo/semantics/altIdentifier/url/https://link.springer.com/article/10.1007%2Fs11010-015-2370-x. ,

Link: http://hdl.handle.net/11..

15

Sensitivity of tumor cells towards CIGB-300 anticancer pept..:

Perera, Yasser ; Costales, Heydi C ; Diaz, Yakelin...
info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/10.1002/psc.1432. ,

Link: http://hdl.handle.net/11..